A possible molecular mechanism for the antiparkinsonian action of bromocriptine in combination with levodopa
- 31 December 1985
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 6, 436-437
- https://doi.org/10.1016/0165-6147(85)90207-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Mechanisms of Membrane-Receptor RegulationNew England Journal of Medicine, 1984
- Effects of dopamine depletion on rotational behavior to dopamine agonistsBrain Research, 1983
- Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- Bromocriptine in ParkinsonismArchives of Neurology, 1978
- Treatment of Parkinson's Disease with BromocriptineNew England Journal of Medicine, 1976
- BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISMThe Lancet, 1976
- Bromocriptine treatment in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPABritish Journal of Pharmacology, 1976
- TREATMENT OF PARKINSONISM WITH BROMOCRIPTINEThe Lancet, 1974
- Tremor and Involuntary Movements in Monkeys: Effect of L-Dopa and of a Dopamine Receptor Stimulating AgentScience, 1973